Corrective Phases R...
Health Care: Drugs
Delcath Systems Inc. (DCTH: NASDAQ)
$1.46 0.02 | 1.39%
06/04/12 - 11:55 AM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 1.44 |
| 52 Week High | 6.64 |
| 52 Week Low | 1.42 |
| Avg. Daily Vol. (Mil) | 0.66 |
| Beta (3 year) | 2.78 |
| Share Related Items | |
| Mkt Cap (Mil) | 72.23 |
| Shares Out (Mil) | 50.16 |
| Float (Mil) | 48.34 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.40 |
| Current Ratio | 2.60 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 0.00 |
| Price/Book | 4.31 |
| Price/Cash Flow | -1.70 |
| Per Share Data | |
| Earnings | -0.95 |
| Sales | 0.00 |
| Book Value | 0.33 |
| Cash Flow | -0.85 |
| Business Summary | |
|---|---|
| Delcath Systems, Inc. is a development stage company focusing on the development of the Delcath PHP System, an innovative drug delivery system designed to treat cancers of the liver. | |
| General Information | |
| 810 Seventh Avenue
35th Floor New York, NY 10019 |
|
| www.delcath.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 93 | |
| CEO: Eamonn P. Hobbs | |
| Short Interest | |
| Current Month (Mil) | 8.58 |
| Previous Month (Mil) | 8.55 |
| Short Interest Ratio (Days) | 27.20 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -171.40 |
| Return on Investments | -261.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with DCTH
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserROSIE
- UserTA stocks
- ContributorBarron's Activist Stocks 8-...
- UserSUPRATRADE 7 Top Stocks for...
- UserASCO 2010
- Contributor10 Biotech Stocks on Clinic...
- ContributorBarron's Insider Purchases ...
- User52 Week High Strategy
Latest DCTH Headlines from TheStreet
- BIO CEO Confab Live Blog: Day 2 02.14.12 | 10:02 am
- Biotech Stock Mailbag: Mela Sciences 09.09.11 | 06:09 am
- Biotech Calendar: Key Dates for September 08.31.11 | 06:08 am
- Biotech Stock Mailbag: Celsion 05.13.11 | 08:05 am
- 'Mad Money Lightning Round': Go for Exelixis 04.26.11 | 07:04 pm
- Biotech Stock Mailbag: Amarin 04.22.11 | 07:04 am
- Sweet Spot in Biotech Investing 04.13.11 | 12:04 pm
- Delcath: Safety Questions Behind FDA Delay 02.23.11 | 07:02 am
- Delcath Hit With FDA Approval Delay 02.22.11 | 10:02 am
- 10 Health Care Stocks With 100% Buy Ratings 01.28.11 | 07:01 am
Press Releases for DCTH
- Delcath Announces First CHEMOSAT Procedures In Germany - PR Newswire 02.27.12 | 06:02 am
- Delcath Announces Updated Efficacy Results From Phase 3 Trial Of Chemosaturation For Melanoma Metastases In The Liver Presented At European Multidisciplinary Cancer Congress - PR Newswire 09.23.11 | 06:09 pm
- Positive Phase 2 Trial Results From Neuroendocrine Tumor Cohort Presented At CIRSE - PR Newswire 09.13.11 | 02:09 am
- Delcath Systems Receives Refusal To File Letter From FDA - PR Newswire 02.22.11 | 05:02 am
- Delcath Achieves ISO 13485 Certification - PR Newswire 02.17.11 | 09:02 am
- Delcath Completes New Drug Application Submission To The FDA For The Chemosaturation Delivery System - PR Newswire 12.22.10 | 07:12 am
- Delcath Submits CE Mark Technical File For Hepatic ChemoSAT⢠Delivery System - PR Newswire 12.06.10 | 06:12 am
- Delcath Names Bernard R. Tyrrell As Senior Vice President For North American Sales And Marketing - PR Newswire 12.01.10 | 06:12 am
- Encompass Fund’s Go-Anywhere Strategy Continues To Excel In 2010 - Business Wire 11.10.10 | 05:11 pm
- Delcath Systems Announces Third Quarter Progress Report Conference Call - PR Newswire 10.27.10 | 06:10 am
Partner Headlines for DCTH
- Active Stock Alerts: Dendreon, Delcath Systems, Johnson & Johnson, Boeing, Onyx June 4th - Wall St. Cheat Sheet 06.04.12 | 10:06 am
- Hyper-Novel Investments For Targeting Cancer - Seeking Alpha 05.30.12 | 09:05 am
- Mid-Day Update: Stocks Trending Water Ahead of First Holiday Weekend of Summer - NASDAQ 05.25.12 | 04:05 pm
- Mid-Day Market Losers - Benzinga 05.25.12 | 01:05 pm
- 4 Stocks Attracting Heavy Trading Interest - Wall St. Cheat Sheet 05.25.12 | 12:05 pm
- Ultimate Market Recap: Talbots Tanks, Facebook Fiasco Continues - Wall St. Cheat Sheet 05.25.12 | 06:05 am
- Company News for January 03, 2012 - Corporate Summary - Zacks 01.03.12 | 10:01 am
- Emisphere: Crown Jewel In Oral B12 - Seeking Alpha 10.07.11 | 09:10 am
- Delcath Announces Updated Efficacy Results from Phase 3 Trial of Chemosaturation for Melanoma Metastases in the Liver - Benzinga 09.23.11 | 06:09 pm
- Friday's Top Performing Small Cap Stocks (MDS, MNKD, FXCM, FOE, DCTH) - NASDAQ 08.15.11 | 01:08 pm
